Pathkey.ai Limited has released a press release.
Appendix 4D & Half Year Results
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Pathkey.AI
- Opyl enters into MSA and new clinical trial recruitment
- Opyl completes Placement and launches Rights Issue
- Suspension from Official Quotation
- Opyl - world-first mapping & linking clinical trial data
- Opyl Receives $570K R&D Tax Refund
Later from Pathkey.AI
- Successful Placement of Shortfall Shares from Rights Issue
- Opyl completes Placement and secures short term loan
- Opyl Announces Leadership Changes & Strategic Realignment
- TrialKey MVP Launched / Strategy Update Webcast
- Opyl Receives $530K R&D Tax Refund
Follow Pathkey.AI into a list and get an email when it puts out news.
Follow Pathkey.AI